We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+13.87%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$19.2B
AUM Growth
+$2.27B
Cap. Flow
+$233M
Cap. Flow %
1.21%
Top 10 Hldgs %
23.73%
Holding
923
New
25
Increased
475
Reduced
375
Closed
12

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$53.8M
2
WTW icon
Willis Towers Watson
WTW
+$43.9M
3
CMCSA icon
Comcast
CMCSA
+$31.7M
4
UBS icon
UBS Group
UBS
+$30.6M
5
CAT icon
Caterpillar
CAT
+$29.8M

Top Sells

Rank Stock Value
1
ALC icon
Alcon
ALC
+$82.9M
2
AON icon
Aon
AON
+$48.6M
3
TT icon
Trane Technologies
TT
+$39.2M
4
DRI icon
Darden Restaurants
DRI
+$38M
5
LUV icon
Southwest Airlines
LUV
+$33M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 14.42%
3 Healthcare 13.44%
4 Consumer Discretionary 12.76%
5 Communication Services 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSII
751
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.57M 0.01%
35,791
-29,014
-45% -$1.09M
JJSF icon
752
J&J Snack Foods
JJSF
$1.71B
$1.56M 0.01%
10,026
-8,127
-45% -$1.18M
FANG icon
753
Diamondback Energy
FANG
$52.7B
$1.54M 0.01%
31,865
-484
-1% -$17.9K
EXPO icon
754
Exponent
EXPO
$3.24B
$1.54M 0.01%
17,082
-13,850
-45% -$1.1M
JOYY
755
JOYY Inc
JOYY
$3.75B
$1.54M 0.01%
19,200
-500
-3% -$43K
MLAB icon
756
Mesa Laboratories
MLAB
$574M
$1.53M 0.01%
5,355
-4,339
-45% -$1.19M
NYT icon
757
New York Times
NYT
$10.2B
$1.53M 0.01%
29,501
-23,918
-45% -$1.06M
BCPC
758
Balchem Corp
BCPC
$5.72B
$1.52M 0.01%
13,179
-10,686
-45% -$1.13M
LSXMK
759
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.51M 0.01%
44,855
-972
-2% -$29.6K
NVRO
760
DELISTED
NEVRO CORP.
NVRO
$1.51M 0.01%
8,720
-7,070
-45% -$1.15M
ATR icon
761
AptarGroup
ATR
$8.61B
$1.51M 0.01%
11,016
-8,930
-45% -$1.11M
DCI icon
762
Donaldson
DCI
$11.4B
$1.51M 0.01%
26,991
-21,884
-45% -$1.15M
GH icon
763
Guardant Health
GH
$22.6B
$1.51M 0.01%
11,697
-9,484
-45% -$1.09M
WINA icon
764
Winmark
WINA
$1.32B
$1.51M 0.01%
8,112
-6,577
-45% -$1.17M
VICR icon
765
Vicor
VICR
$10.2B
$1.5M 0.01%
16,221
-13,150
-45% -$1.1M
AGIO icon
766
Agios Pharmaceuticals
AGIO
$1.93B
$1.49M 0.01%
34,412
-27,896
-45% -$1.1M
AOS icon
767
A.O. Smith
AOS
$8.7B
$1.49M 0.01%
27,206
-16,100
-37% -$887K
RNST icon
768
Renasant Corp
RNST
$3.91B
$1.49M 0.01%
44,205
+2,691
+6% +$82.2K
AMH icon
769
American Homes 4 Rent
AMH
$12.5B
$1.49M 0.01%
49,580
CCXI
770
DELISTED
ChemoCentryx, Inc.
CCXI
$1.48M 0.01%
23,840
-19,326
-45% -$1.11M
EGRX
771
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.47M 0.01%
31,645
-25,655
-45% -$1.2M
FIZZ icon
772
National Beverage
FIZZ
$3.01B
$1.47M 0.01%
34,692
-28,122
-45% -$1.21M
XLRN
773
DELISTED
Acceleron Pharma
XLRN
$1.47M 0.01%
11,513
-9,333
-45% -$1.09M
AAON icon
774
Aaon
AAON
$7.77B
$1.47M 0.01%
33,149
-26,874
-45% -$1.14M
FUL icon
775
H.B. Fuller
FUL
$3.28B
$1.47M 0.01%
28,290
+6,254
+28% +$317K

Similar funds

Aviva's Q4 2020 Portfolio in Review

As of Q4 2020, Aviva held 923 positions worth $19.2B, up 13% from $17B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 4%. Aviva opened 25 new positions and exited 12, leaving the 923-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q4 2020 buy was Valvoline: 871,000 shares worth $20.2M.
  • Aviva added most to Charter Communications in Q4 2020, an estimated $53.8M increase.
  • Aviva's biggest Q4 2020 reduction was Alcon, cutting an estimated $82.9M.
  • Aviva fully exited Aimco in Q4 2020, selling an estimated $3.69M.
  • Aviva's ten largest holdings make up 24% of its $19.2B portfolio in Q4 2020.
  • Aviva opened 25 new positions and closed 12 in Q4 2020.
  • Aviva's portfolio value rose 13% quarter-over-quarter to $19.2B.

Based on Aviva's 13F filing for Q4 2020, filed 10 Feb 2021.